Dynamics of TCR Repertoire Following Thymus Transplant
胸腺移植后 TCR 的动态变化
基本信息
- 批准号:7224913
- 负责人:
- 金额:$ 36.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-15 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AllogenicAllograftingAppearanceAreaBiological ModelsBone Marrow Stem CellBone Marrow TransplantationCD3 AntigensCD8B1 geneCell CountCellsComputer SimulationDNA Sequence RearrangementDataDefectDevelopmentDiGeorge SyndromeDonor personEnlargement of lymph nodesEnrollmentEpitheliumEvolutionExanthemaExcisionFamilyFlow CytometryFrequenciesGenesGeneticGenetic RecombinationGrowthHeartHomeostasisHumanImmuneImmunodeficiency and CancerInfantInterleukin-7LigandsLymphatic DiseasesMaintenanceMeasuresModelingOutputParathyroid glandPatientsPatternPeptide Signal SequencesPeptide/MHC ComplexPeripheralPopulationPopulation DynamicsPopulation GrowthPre-studyProductionProtocols documentationPublishingRateRegulationRelative (related person)ResearchResearch PersonnelResourcesRoleSamplingSecondary toSelection BiasSerumSignal TransductionStagingSystemT cell regulationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingThinkingThymus GlandTimeTissuesTransplantationVariantbasecytokinedensityinsightinterestmanmathematical modelmemberpostnatalpostnatal humanprogramsreconstitutionthymus transplantation
项目摘要
DESCRIPTION (provided by applicant):
The long term objective of this proposal is to identify mechanisms regulating human T cell diversity. We propose to do so using a model system of infants with complete DiGeorge syndrome who receive thymic allografts. Infants with DiGeorge syndrome are born with defects in the thymus, heart, and parathyroid glands. Patients with "complete" DiGeorge syndrome have no evidence ofthymic function. Twenty four patients have been treated in a separate, well-established research protocol by transplantation with allogeneic cultured postnatal human thymus. Seventeen patients survive, all with good immune reconstitution and function. The mechanism of T cell development in these patients is host bone marrow stem cells going to the transplanted donor thymic epithelium and developing there into mature host T cells. In the first specific aim, we will examine the mechanisms underlying selection of T cell receptor (TCR) variable-beta gene segments (TCRBV) in newly formed T cells. We hypothesize that early TCRBV usage is biased toward those gene segments that are associated with highly efficient recombination signal sequences (RSS) and toward those that are most proximal to the TCRBJ cluster. We will compare the selection in the early oligoclonal T cell populations, which develop at 3-4 months after transplantation, to those present at 1 year. In aim 3, we will examine T cells in "atypical" complete DiGeorge patients who develop oligoclonal T cells prior to thymus transplantation. These T cells are associated with rash and lymphadenopathy. The same hypothesis will be tested regarding TCRBV selection - that it is based on RSS efficiency and TCRBJ proximity. These T cells develop without thymic input, so the effect of thymic selection on TCRBV usage will be ascertained. In aim 2, we will use mathematical modeling and multivariate statistical analysis of patient data to evaluate the relationship between T cell hemeostasis and TCRBV diversity with emphasis on distinguishing the roles of TCR-specific resources (e.g., MHC-peptide complexes) and TCR non-specific resources, such as IL-7. Thus, this unique model of thymus development will provide insights into development of T cell diversity in man. These findings will have application to thymus and bone marrow transplantation for immunodeficiency and cancer.
描述(由申请人提供):
这项提议的长期目标是确定调节人类T细胞多样性的机制。我们建议使用接受同种异体胸腺移植的完全性DiGeorge综合征婴儿的模型系统来实现这一点。患有迪乔治综合征的婴儿出生时就有胸腺、心脏和甲状旁腺的缺陷。“完全性”迪乔治综合征患者没有胸腺功能的证据。24名患者通过移植同种异体培养的出生后人类胸腺进行了单独的、完善的研究方案的治疗。17名患者幸存下来,均有良好的免疫重建和功能。这些患者的T细胞发育机制是宿主骨髓干细胞进入移植的供者胸腺上皮,并在那里发育为成熟的宿主T细胞。在第一个特定目标中,我们将研究在新形成的T细胞中选择T细胞受体(TCR)可变β基因片段(TCRBV)的机制。我们假设早期TCRBV的使用偏向于那些与高效重组信号序列(RS)相关的基因片段,以及那些最接近TCRBJ簇的基因片段。我们将比较在移植后3-4个月发育的早期寡克隆性T细胞群体中的选择与在一年时出现的选择。在目标3中,我们将检测胸腺移植前出现寡克隆T细胞的“非典型”完全性DiGeorge患者的T细胞。这些T细胞与皮疹和淋巴结病有关。关于TCRBV的选择将检验相同的假设--它基于RSS效率和TCRBJ近似性。这些T细胞在没有胸腺输入的情况下发育,因此胸腺选择对TCRBV使用的影响将被确定。在目标2中,我们将使用数学建模和患者数据的多元统计分析来评估T细胞血液稳定性和TCRBV多样性之间的关系,重点是区分TCR特异性资源(如MHC-肽复合体)和TCR非特异性资源(如IL-7)的作用。因此,这种独特的胸腺发育模型将为人类T细胞多样性的发展提供洞察力。这些发现将应用于胸腺和骨髓移植治疗免疫缺陷和癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Louise MARKERT其他文献
M. Louise MARKERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Louise MARKERT', 18)}}的其他基金
Phase I Serum-free cultured thymus transplantation in DiGeorge anomaly, IND9836,
DiGeorge 异常的 I 期无血清培养胸腺移植,IND9836,
- 批准号:
7565124 - 财政年份:2009
- 资助金额:
$ 36.5万 - 项目类别:
Thymic Transplantation in Complete DiGeorge Syndrome
完全性迪乔治综合征的胸腺移植
- 批准号:
7931554 - 财政年份:2009
- 资助金额:
$ 36.5万 - 项目类别:
THYMUS TRANSPLANTATION IN COMPLETE DIGEORGE SYNDROME
完全性迪乔治综合征的胸腺移植
- 批准号:
7198447 - 财政年份:2005
- 资助金额:
$ 36.5万 - 项目类别:
PARATHYROID AND THYMUS TRANSPLANTS IN DIGEORGE SYNDROME
迪乔治综合征中的甲状旁腺和胸腺移植
- 批准号:
7198503 - 财政年份:2005
- 资助金额:
$ 36.5万 - 项目类别:
Dynamics of TCR Repertoire Following Thymus Transplant
胸腺移植后 TCR 的动态变化
- 批准号:
7392216 - 财政年份:2004
- 资助金额:
$ 36.5万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 36.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 36.5万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 36.5万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 36.5万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:














{{item.name}}会员




